慢性心力衰竭(chronicheartfailure, CHF) 是各类心血管疾病的终末期阶段. CHF
的治疗方案近年虽不断完善, 但仍有较高的死亡率与住院率, 给患者及家庭带来了巨大的医疗 …

Acute myocardial infarction is an important cardiovascular disease worldwide. Although the
mortality rate of myocardial infarction (MI) has improved dramatically in recent years due to …

Interleukin-1 (IL-1) blockade with anakinra given within 12 hours from reperfusion has been
shown to reduce the inflammatory response as well as prevent heart failure (HF) events in …

Background: Interleukin-1 blockade with anakinra leads to a transient increase in eosinophil
blood count (eosinophils) in patients with acute myocardial infarction. We aimed to …

Long after Trypanosoma cruzi infection, 40% of individuals develop a progressive chronic
chagasic cardiomyopathy (CCC), with systolic dysfunction and arrhythmias. Since we …

Coronary artery disease (CAD) is one of the major causes of morbidity and mortality in the
western world. Despite major improvements in treatment in the acute phase, myocardial …

Abstract Purpose of Review The balance between inflammation and its resolution plays an
important and increasingly appreciated role in heart failure (HF) pathogenesis. In humans …

Background. Anakinra, an IL-1 inhibitor, temporarily increases eosinophil blood levels in
patients with acute myocardial infarction and reduces heart failure (HF) events. Anakinra is …

Background Heart failure is a serious heart ailment that affects millions of people globally in
terms of their quality of life and general health. In the development and pathophysiology of …

Chronic heart failure (CHF) is the terminal stage of cardiovascular disease. Although the
treatment of CHF has been continuously improved in recent years, there are still high …